Cargando…

Opioid antagonism modulates wanting-related frontostriatal connectivity

Theoretical accounts distinguish between motivational (‘wanting’) and hedonic (‘liking’) dimensions of rewards. Previous animal and human research linked wanting and liking to anatomically and neurochemically distinct brain mechanisms, but it remains unknown how the different brain regions and neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Soutschek, Alexander, Weber, Susanna C, Kahnt, Thorsten, Quednow, Boris B, Tobler, Philippe N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598157/
https://www.ncbi.nlm.nih.gov/pubmed/34761749
http://dx.doi.org/10.7554/eLife.71077
_version_ 1784600755544522752
author Soutschek, Alexander
Weber, Susanna C
Kahnt, Thorsten
Quednow, Boris B
Tobler, Philippe N
author_facet Soutschek, Alexander
Weber, Susanna C
Kahnt, Thorsten
Quednow, Boris B
Tobler, Philippe N
author_sort Soutschek, Alexander
collection PubMed
description Theoretical accounts distinguish between motivational (‘wanting’) and hedonic (‘liking’) dimensions of rewards. Previous animal and human research linked wanting and liking to anatomically and neurochemically distinct brain mechanisms, but it remains unknown how the different brain regions and neurotransmitter systems interact in processing distinct reward dimensions. Here, we assessed how pharmacological manipulations of opioid and dopamine receptor activation modulate the neural processing of wanting and liking in humans in a randomized, placebo-controlled, double-blind clinical trial. Reducing opioid receptor activation with naltrexone selectively reduced wanting of rewards, which on a neural level was reflected by stronger coupling between dorsolateral prefrontal cortex and the striatum under naltrexone compared with placebo. In contrast, reducing dopaminergic neurotransmission with amisulpride revealed no robust effects on behavior or neural activity. Our findings thus provide insights into how opioid receptors mediate neural connectivity related to specifically motivational, not hedonic, aspects of rewards.
format Online
Article
Text
id pubmed-8598157
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-85981572021-11-19 Opioid antagonism modulates wanting-related frontostriatal connectivity Soutschek, Alexander Weber, Susanna C Kahnt, Thorsten Quednow, Boris B Tobler, Philippe N eLife Neuroscience Theoretical accounts distinguish between motivational (‘wanting’) and hedonic (‘liking’) dimensions of rewards. Previous animal and human research linked wanting and liking to anatomically and neurochemically distinct brain mechanisms, but it remains unknown how the different brain regions and neurotransmitter systems interact in processing distinct reward dimensions. Here, we assessed how pharmacological manipulations of opioid and dopamine receptor activation modulate the neural processing of wanting and liking in humans in a randomized, placebo-controlled, double-blind clinical trial. Reducing opioid receptor activation with naltrexone selectively reduced wanting of rewards, which on a neural level was reflected by stronger coupling between dorsolateral prefrontal cortex and the striatum under naltrexone compared with placebo. In contrast, reducing dopaminergic neurotransmission with amisulpride revealed no robust effects on behavior or neural activity. Our findings thus provide insights into how opioid receptors mediate neural connectivity related to specifically motivational, not hedonic, aspects of rewards. eLife Sciences Publications, Ltd 2021-11-11 /pmc/articles/PMC8598157/ /pubmed/34761749 http://dx.doi.org/10.7554/eLife.71077 Text en © 2021, Soutschek et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Neuroscience
Soutschek, Alexander
Weber, Susanna C
Kahnt, Thorsten
Quednow, Boris B
Tobler, Philippe N
Opioid antagonism modulates wanting-related frontostriatal connectivity
title Opioid antagonism modulates wanting-related frontostriatal connectivity
title_full Opioid antagonism modulates wanting-related frontostriatal connectivity
title_fullStr Opioid antagonism modulates wanting-related frontostriatal connectivity
title_full_unstemmed Opioid antagonism modulates wanting-related frontostriatal connectivity
title_short Opioid antagonism modulates wanting-related frontostriatal connectivity
title_sort opioid antagonism modulates wanting-related frontostriatal connectivity
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598157/
https://www.ncbi.nlm.nih.gov/pubmed/34761749
http://dx.doi.org/10.7554/eLife.71077
work_keys_str_mv AT soutschekalexander opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity
AT webersusannac opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity
AT kahntthorsten opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity
AT quednowborisb opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity
AT toblerphilippen opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity